Modification to Affymetrix GeneChip Microarray Instrumentation System
FDA 510(k)Class II (US FDA 510(k))
Identifiers
- 510(k) Number
- K080995 FDA 510(k)
- FDA Product Code
- NSU FDA 510(k)
Classification
- Device Class
- Class II FDA 510(k)
- Legislation / Framework
- 21 CFR Part 862.2570 FDA 510(k)
- Regulation Number
- 862.2570 FDA 510(k)
- Advisory Committee
- Clinical Chemistry FDA 510(k)
- FDA Decision
- SESE Substantially Equivalent FDA 510(k)
The Modification to Affymetrix GeneChip Microarray Instrumentation System is a laboratory-based diagnostic tool used to analyze genetic material. It consists of the GeneChip 3000Dx scanner with an autoloader, the FS450Dx fluidics station, and GCOSDx software. The system performs hybridization, washing, scanning, and data analysis of GeneChip microarrays.
This modification is intended for use in clinical chemistry laboratories. The device is supplied as a system with multiple components and requires appropriate storage conditions. It has received FDA 510(k) clearance with the product code NSU and is classified as Instrumentation For Clinical Multiplex Test Systems.
This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Modification To Affymetrix Genechip Microarray Instrumentation System ..., Modification to Affymetrix Genechip Microarray Instrumentation System ..., PDF Microsoft Word - k080995-jvc.doc - Food and Drug Administration, www.accessdata.fda.gov
Authorization Coverage (1 country)
Regulatory Authorizations
FDA_510K
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA 510(k) | United States | FDA_510K | K080995 | Class II | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Affymetrix, Inc.
Sources (1)
- FDA 510(k) K080995 24 fields · synced Sep 22, 2026